"Medical Speed Reading Society" Gibel Listing China team found to block new coronal infection antibodies

May 17, 14 new cases of asymptomatic infection in Hubei, Chinese team found to block antibodies to new coronal infections, Gibelco's successful launch of the board, and the first radon drug, Austedo China, approved for theAt 0-24 hours on the 17th, 31 provinces (autonomous regions, municipalities directly under the central government) and Xinjiang Production and Construction Corps reported 7 new confirmed cases, including 4 cases imported from abroad (4 cases in Inner Mongolia) and 3 cases of local cases (2 cases in Jilin, 1 case in Shanghai); (The official website of the National Health and Health Commission)17, the province added 14 new asymptomatic infections, 10 cases, diagnosis of 0 cases, the lifting of isolation 77 cases, still under medical observation of asymptomatic infection 337 cases(Hubei Province Health and Health Commission)18 news, The Chinese scientific research team recently published a paper in the U.Sjournal Science said that they found two human-derived monoclonal antibodies that can effectively block the infection of new coronavirus, is expected to be used in the development of anti-new coronary drugs and vaccinesToday, Jiangsu Jibel officially listed on the Shanghai Stock Exchange, the stock short for "Jibel", the stock code "688566", the issue price of 23.69 yuan / shareOn the first day of trading, Gibel opened at 49.50 yuan, up or down 106.29%(EYeo Da Health)18 news, Ping An good doctor issued a notice that due to MrWang Tao's personal reasons, the board of directors decided to remove its chairman, executive director, ceoOn the same day, the Board appointed MrFang Weihao as Executive Director, Interim Chairman of the Board and Chief Executive OfficerThe appointment and removal notice took effect on Friday (May 15)(Ping An Good Doctor)18, AstraZeneca and First Iii jointly announced that the joint development of the target HER2 antibody conjugate drug (ADC) Enhertu (fam-trastuzumabderuxtecan-nxki) was awarded by the U.SFDA breakthrough therapy for the treatment of HER2 positive, in platinum treatment or after treatment of the progress of the disease in metastatic non-small cell lung cancer patients18, Teva Pharmaceutical Information Consulting (Shanghai) Co., Ltdannounced that its innovative drug Antitan ® (thorium-depreennidate tablets) has been approved by the State Drug Administration for priority review and approval, officially approved for the treatment of Huntington's disease-related dance diseases and adult delayed motor disorders(Sina Pharmaceutical News)18, Green Leaf Pharmaceuticals announced that its innovative drug to treat Alzheimer's disease - Liss's Mingdo-day transdermal paste (commodity name Rivalif®, product number LY30410) has been accepted by the European Union authoritiesDeveloped by the Transderating Drug Technology Platform of the German subsidiary Luye Pharma AG, the drug is a core product of the Group in the field of central neurotherapy, BlueprintMedicine announced that the FDA has issued a full response letter (CRL) to a new drug application for the targeted anti-cancer drug Avakit (avapritinib) for the treatment of gastrointestinal intermediatic sylloma (GIST)THE CRL NOTES THAT THE FDA CANNOT APPROVE THE FOUR-LINE TREATMENT OF GIST NDA(Bio Valley)Mersadon recently announced the results of phase II trial (NCT03401788) of the hypoxia-inducing factor-2 alpha (HIF-2 alpha) inhibitor MK-6482MK-6482 is a novel candidate drug in the company's oncology pipeline for the treatment of transparent cell renal cell carcinoma associated with Hipper Lindo syndromeClinical data show that MK-6482 showed long-lasting remission, with a confirmed objective remission rate of 27.9% and median remission duration not yet reached(Bio Valley)Xinhua Pharmaceuticals issued a notice on the evening of the 18th, the company recently received the State Drug Administration approved the issuance of ibuprofen tablets (0.1g and 0.2g) "drug supplementary application approval", the product through the consistency evaluation of generic drugsThe company became the first domestic ibuprofen tablet0.2g, 0.1g second through the product agency consistency evaluation of the drug(Xinhua Pharmaceutical Bulletin)Haizheng Pharmaceutical son released on the 18th, said that recently, the company received the Approval of the State Drug Administration for the issuance of the "drug supplementary application approval" for McCo-phenol capsules, the company's do-for-McCorcorhethane capsules have passed the quality and efficacy consistency evaluation of generic drugs (Haizheng PharmaceuticalS Announcement)